Today, dsm-firmenich reported sales of €6.298 billion, marking a 2% year-on-year increase in the first half of 2024. CEO Dimitri de Vreeze expressed satisfaction with the company’s accomplishments over these six months. He highlighted the successful launch of their strategic plan during the capital markets day in June and noted significant progress in both synergy initiatives and the vitamin transformation programs.
Specifically, the Perfumery & Beauty were exceptionally strong, including good contribution from recovery in Ingredients. It recorded €1.021 billion in sales, with a year-on-year change of 13% in Q2 of 2024. The company said that the segment was very strong result with double-digit volume growth across all 3 business lines: Perfumery continued good growth in Fine Fragrances, while demand for Consumer Fragrances was exceptionally strong. Ingredients was strong demand across all end-use segments. Beauty & Care continued positive momentum for both its beauty actives and for its hair, skin, and sun offerings, supported by sales synergies.
De Vreeze emphasized that their unwavering focus on operational excellence, coupled with improving market conditions, has led to enhanced financial results. Both the Perfumery & Beauty (P&B) and Taste, Texture & Health (TTH) segments delivered robust performances. Additionally, the Health, Nutrition & Care (HNC) and Animal Nutrition & Health (ANH) divisions showed improved momentum.
